Crossref
Two-year analysis of CodeBreaK 100 phase I/II trial: achieved goals of an ongoing challenge
AME Clinical Trials Review · 2023
DOI: 10.21037/actr-23-18 ↗Kurz gefasst
Fachartikel in der Zeitschrift AME Clinical Trials Review, 2023. Verfasst von Valentina Santo und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Santo, V., Brunetti, L., & Cortellini, A. (2023). Two-year analysis of CodeBreaK 100 phase I/II trial: achieved goals of an ongoing challenge. AME Clinical Trials Review. https://doi.org/10.21037/actr-23-18
Vancouver
Santo V, Brunetti L, Cortellini A. Two-year analysis of CodeBreaK 100 phase I/II trial: achieved goals of an ongoing challenge. AME Clinical Trials Review. 2023. doi:10.21037/actr-23-18
BibTeX
@article{Santo2023,
author = {Santo, Valentina and Brunetti, Leonardo and Cortellini, Alessio},
title = {Two-year analysis of CodeBreaK 100 phase I/II trial: achieved goals of an ongoing challenge},
journal = {AME Clinical Trials Review},
year = {2023},
doi = {10.21037/actr-23-18}
}
EUVIMED